UQ is investing in new health and medical research models and new capabilities to address our most pressing health and medical research and innovation challenges.
Transforming the health and wellbeing of societies requires a highly collaborative and interdisciplinary research approach. Through the Vice Chancellor's Health Research Accelerator (HERA) initiative, our researchers are augmenting the health and medical research capabilities of UQ and its partners and delivering collaborative solutions that amplify the impact on human health.
Our vision
Through the HERA initiative, we want to:
- catalyse interdisciplinary research programs nationally and internationally
- grow national and international funding with industry, partners, philanthropists, and
- grow industry partnerships for knowledge exchange to drive outcomes for transformative health and medical research impact of human health.
In doing this, we will help to address the major health challenges of our time.
Our research programs include:
Development of mRNA vaccines
This program will invest in critical expertise focused on mRNA technology, vaccine delivery, bacterial vaccine genomincs and vaccine immunology, resulting in transformative mRNA vaccine development.
EvolveHealth Health Workforce Optimisation
Globally, healthcare systems are struggling through rising costs, critical staff shortages, increasing demand, more expensive technologies and the growing burden of chronic conditions are straining services and systems.
Our EvolveHealth program is redefining the future of work in Australia's healthcare sector.
Groups and Relationships to Optimise Wellbeing and Health (GROWTH)
Social isolation can affect anyone. It also places huge pressures on health services – estimates suggest that around 10 per cent of adults suffer from its debilitating consequences, and that GPs spend around 20 per cent of their time dealing with non-health problems.
GROWTH is pioneering a new community-focused approach to combating loneliness.
Operational Research and Decision Support for Prevention, Control and Elimination of Infectious Diseases (ODeSI)
Emerging infectious diseases (EIDs), vaccine preventable diseases (VPDs) and neglected tropical diseases (NTDs) are of international significance, especially in Asia-Pacific, and present many mutual challenges.
Our ODeSI program is enhancing the effectiveness of EID, NTD and VPD management in Australasia.
The University of Queensland's Clinical Trials Capability (ULTRA)
Randomised Controlled Trials (RCTs) are an important component of the healthcare system as they provide gold standard, robust evidence about the comparative effectiveness and cost-effectiveness of interventions. Evidence from RCTs transforms healthcare, shapes decisions about healthcare expenditure and improves the health of the population.
The ULTRA program is innovating the RCT lifecycle to improve result times and patient outcomes.
360 Kids Community Network
A quarter of Australian children are developmentally vulnerable at entry to school. The social, wellbeing, and developmental challenges they face increases their lifelong risks for poor health and academic outcomes. Without prevention or early intervention these children are at much greater risk for lifestyle-related chronic disease, health, social and educational challenges.
The 360 Kids Network is improving the life trajectory for vulnerable children.
Queensland Digital Health Centre (QDHeC)
Healthcare as it is currently delivered in Australia is not sustainable. Health systems are straining under rising costs, increasing demand and growing wait times. The Queensland Digital Health Centre will become the engine room of our digital healthcare future.
QDHeC is transforming digital healthcare for Queenslanders.
The Program of Research and Innovation involves 9 UQ facilities and institutes and over 115 researchers – making this a truly multi-disciplinary collaboration initiative.
UQ committed $50 million to the HERA Programs of Research and Innovation to recruit outstanding researchers with the knowledge, skills and expertise to augment the health and medical capabilities of UQ and its partners to deliver collaborative solutions that amplify the impact on human health.
Of the 28 positions earmarked as part of this funding, 26 outstanding researchers have now joined the HERA team.
EvolveHealth Workforce Optimisation
GROWTH
Associate Professor Magnolia Cardona
Development of mRNA vaccines
Operational Research and Decision Support for Prevention, Control and Elimination of Infectious Diseases
Associate Professor Benn Sartorius
Queensland Digital Health Centre
Dr Riddhi Gupta
Associate Professor Bevan Koopman
The University of Queensland’s cLinical TRials cApability
Associate Professor Ingrid Hickman
360-Kids Network
Annual HERA Showcase
For more information, please contact the HERA team via hera@research.uq.edu.au.
See our research news
UQ to establish world-leading mRNA labQCIF and UQ head to iAwards national finalUQ health project making a difference to First Nations mums and bubsQDHeC leading a ‘digital health revolution’ to tackle chronic diseases
Forging global partnerships and connectivity is at the heart of UQ’s vision to deliver knowledge leadership for a better world.
HERA provides the scale and intensity needed to make real breakthroughs by connecting people and capabilities from across the UQ with partners in industry, government and other organisations who interact with the health and medical needs of the community.
For more information about any of the HERA programs and potential partnering opportunities, email hera@research.uq.edu.au.
Current partners
Over 80 local, national, and international partners are involved in one or more of our HeRA programs. Our partners and stakeholders play a crucial role in ensuring new capabilities enable transformative outcomes and impacts.
Our partners include:
- Australian Clinical Trials Alliance (ACTA)
- Australian Defence Force Malaria and Infectious Diseases Institute (ADFMIDI)
- Australian National University (ANU)
- ACT Education Directorate
- Ballycara
- Bionet-Asia
- Bolton Clarke
- Children’s Health Queensland (CHQ)
- Clinical Excellence Queensland (CEQ)
- Clinical Research & Evidence Synthesis at Travel Medicine Alliance (CRESTMA)
- Coalition for Operational Research on NTDs (COR-NTD), Task Force for Global Health, USA
- CSIRO Australian e-Health Research Centre
- Harvard Humanitarian Initiative (Program on Infectious Diseases and Epidemics
- Health and Wellbeing Queensland (HWQld)
- Health Translation Queensland (HTQ)
- Immunisation Coalition
- James Cook University (JCU) - WHO Collaborating Centre for Vector-borne and Neglected Tropical Diseases
- Lives Lived Well
- Mater Health
- Metro North Health (MNH)
- Metro South Health (MSH)
- Moderna
- National Centre for Immunisation Research & Surveillance (NCIRS)
- QIMR Berghofer
- Queensland Health
- Queensland Office of the Chief Allied Health Officer (OCAHO)
- Queensland Office of the Chief Nursing and Midwifery Officer (OCNMO)
- Queensland Office of the Chief Dental Officer (OCDO)
- Queensland University of Technology (QUT) - Centre for Data Science
- Relationships Australia
- Royal Australian College of General Practitioners (RACGP)
- Southern Queensland Rural Health (SQRH)
- Stryker
- Technovalia
- The Queensland Cyber Infrastructure Foundation (QCIF)
- The Salvation Army
- Vaxxas
Contact us
Get in touch to learn more about our research.
HERA is supported by a small team staff from the major initiatives team in UQ’s Research Office.
Dr Madonna Devaney
Associate Director, Major Initiatives
(07) 3365 4582 m.devaney@uq.edu.au
Ms Isobella Scott
Project Coordinator